From Model to Medicine: An AWS Executive Reception at AI x Bio Summit

​As AI-native approaches reshape how therapeutics are discovered and developed, join AWS and Avahi for an exclusive, invite-only reception after the Decoding Bio AI x Bio Summit. The reception brings together enterprise pharma leaders, life sciences investors, and AI-native startup founders to define the next frontier of AI x Biology at scale. This intimate dialogue will bring together the builders and buyers shaping how AI transforms drug discovery, where compute demands are heading, and what it takes to move from research breakthrough to clinical impact, from model development to enterprise deployment.

​What to Expect:
- An executive-level panel moderated by AWS.
- Perspectives from senior executives in pharma, venture capital, and AI-native biotech.
- A focused dialogue on scaling AI in pharma and where capital is flowing in AI x Bio.
- A candid, off-the-record dialogue.
- Networking over hors d'oeuvres and premium cocktails from our friends at Mezcali, a short walk from NYSE. 

In Partnership With Avahi:
An AWS Premier Tier Services Partner delivering advanced AI and cloud solutions that accelerate digital transformation. Known for its speed, technical depth, and customer-centric delivery model, Avahi helps businesses across industries scale faster, optimize costs, and modernize operations on AWS.

Speakers:
- Ashwini Ghogare, PhD, MBA – Sr. Global Life Sciences GenAI BD - AWS
- Ben Liu – CEO and Co-Founder – Formation Bio
- Daniel Smith, PhD – CTO – Achira
- Eli Berlin – Co-Founder – Terray Therapeutics
- Julie Wolf, PhD – Partner – 2048 Ventures